On Monday, the U.S. Supreme Court is set to hear oral arguments in a legal dispute centering on claims that Royal Canin USA Inc. and Nestlé Purina PetCare Co. misrepresented their pet food products as prescription items. The primary question at issue is whether the case should be adjudicated in state or federal court. The decision could have significant implications for how prescription labels on pet foods are regulated and litigated across jurisdictions.
The complexities of jurisdiction and labeling in consumer products law underpin this case, reflecting broader concerns within the legal and business communities about the standards for marketing and product claims.
Read more on Law360